Key Points Interested in Opus Genetics, Inc.? Here are five stocks we like better. Opus Genetics highlighted a broad ...
Morning Overview on MSN
Scientists just mapped how a common class of viruses pries open human cells — the same break-in move behind polio, heart inflammation, and the common cold
A team led by structural biologists at the University of Maryland, Baltimore County has produced the most detailed picture ...
USP recognizes CryoTEM for characterizing empty/full/intermediate capsids on AAV8 reference standards STOCKHOLM, ...
International HIV publication further validates the DeepChek® brand for HIV genotyping and long- & short-read NGS, ...
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the ...
Shares of Immunovant Inc. (NASDAQ:IMVT) were up 30% in midmorning trading after the firm disclosed early but “compelling” data from a phase IIb study testing next-generation FcRn inhibitor IMVT-1402 ...
Research Describes the Potential of JCR’s Platform Technologies, Including JUST-AAV Gene Therapy, to Facilitate Delivery of Therapies to the Central Nervous System -HYOGO, Japan--(BUSINESS WIRE)--JCR ...
CMS College researchers developed SPHAK, a model predicting cross-species virus transmission with over 97% accuracy using viral protein analysis.
RICHMOND, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (OTCQB Venture Market: SGMO), a genomic medicine company, today reported recent business highlights and first quarter 2026 ...
Kell calls hantaviruses “wild,” with sporadic outbreaks. Doing a clinical trial on a possible therapy or vaccine for such a ...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the best small cap stocks to buy for 10x potential. Taysha Gene Therapies ...
Affinia Therapeutics ("Affinia"), an innovative clinical-stage gene therapy company with a pipeline of first-in-class and/or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results